To provide a reference for the further clinical promotion，application，and research development of Mongolian medicine Anshen Buxin Liuwei Pills(Jiruhe-6).Methods:The Delphi method was employed，involving a review of relevant literature，group discussions，and semi-structured interviews to initially determine the hierarchical structure and entry pool of the expert consensus questionnaire regarding the formula composition and clinical application characteristics of Anshen Buxin Liuwei Pills.Online and on-site surveys were distributed to experts engaged in the clinical practice，research，teaching，and production of Mongolian medicine.The consultation aimed to evaluate the current formula composition and clinical application characteristics of Anshen Buxin Liuwei Pills until consensus was reached，resulting in the final formulation of the expert consensus on its composition and clinical application.Results:A total of 42 experts participated in the two rounds of consultation.Based on literature review，group discussions，and semi-structured interviews，the first round of consultation involved 16 inquiry indicators.After revising the indicator system based on expert feedback，the second round included 17 inquiry indicators.Through two rounds of consultation，consensus was reached on 17 entries concerning the formula composition and clinical application of Anshen Buxin Liuwei Pills，covering aspects such as its composition，dosage，primary and comorbid conditions，and optimal medication times.Conclusion:The consensus revealed that replacing wild yak heart with cow heart in Anshen Buxin Liuwei Pills still resulted in good therapeutic efficacy with low clinical risk.